TherapeuticsMD, Inc. (TXMD)
2.21
-0.03
(-1.34%)
USD |
NASDAQ |
Sep 04, 16:00
2.17
-0.04
(-1.81%)
After-Hours: 20:00
TherapeuticsMD EPS Diluted (Quarterly) : 0.0133 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0133 |
| March 31, 2026 | 0.0082 |
| December 31, 2025 | -0.0535 |
| September 30, 2025 | 0.0131 |
| June 30, 2025 | 0.0476 |
| March 31, 2025 | -0.0565 |
| December 31, 2024 | 0.0218 |
| September 30, 2024 | -0.0528 |
| June 30, 2024 | -0.0945 |
| March 31, 2024 | -0.0636 |
| December 31, 2023 | -0.0766 |
| September 30, 2023 | -0.3157 |
| June 30, 2023 | -0.2362 |
| March 31, 2023 | -0.3694 |
| September 30, 2022 | -3.128 |
| June 30, 2022 | 12.83 |
| March 31, 2022 | -5.691 |
| December 31, 2021 | -5.026 |
| September 30, 2021 | -5.616 |
| June 30, 2021 | -5.412 |
| March 31, 2021 | -5.671 |
| December 31, 2020 | -7.342 |
| September 30, 2020 | -5.982 |
| June 30, 2020 | -9.559 |
| March 31, 2020 | -10.47 |
| Date | Value |
|---|---|
| December 31, 2019 | -9.443 |
| September 30, 2019 | -6.625 |
| June 30, 2019 | -11.45 |
| March 31, 2019 | -8.196 |
| December 31, 2018 | -8.256 |
| September 30, 2018 | -7.804 |
| June 30, 2018 | -7.50 |
| March 31, 2018 | -5.50 |
| December 31, 2017 | -5.00 |
| September 30, 2017 | -3.50 |
| June 30, 2017 | -5.00 |
| March 31, 2017 | -5.50 |
| December 31, 2016 | -6.00 |
| September 30, 2016 | -6.50 |
| June 30, 2016 | -5.50 |
| March 31, 2016 | -5.50 |
| December 31, 2015 | -5.00 |
| September 30, 2015 | -5.50 |
| June 30, 2015 | -8.00 |
| March 31, 2015 | -6.50 |
| December 31, 2014 | -5.00 |
| September 30, 2014 | -6.00 |
| June 30, 2014 | -3.50 |
| March 31, 2014 | -3.00 |
| December 31, 2013 | -3.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.164M |
| Revenue (Quarterly) | 0.869M |
| Total Expenses (Quarterly) | 0.705M |
| Enterprise Value | 21.95M |
| Gross Profit Margin (Quarterly) | 62.14% |
| Profit Margin (Quarterly) | 18.87% |
| Earnings Yield | -0.86% |
| Normalized Earnings Yield | -0.5792 |